← Back to Clinical Trials
Recruiting NCT07324863

NCT07324863 Ultrasound Guided External Oblique and Rectus Abdominis Plane Block (EXORA) on Neuroendocrine Stress Response in Adults Undergoing Umbilical Hernia Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07324863
Status Recruiting
Phase
Sponsor Tanta University
Condition Ultrasound
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2025-08-01
Primary Completion 2026-09-01

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
General anesthesiaExternal oblique and rectus abdominis plane (EXORA) block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2025-08-01 with a primary completion date of 2026-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the efficacy of ultrasound-guided external oblique and rectus abdominis plane block on the neuroendocrine stress response and postoperative analgesia in adults undergoing umbilical hernia repair.

Eligibility Criteria

Inclusion Criteria: * Aged from 21 to 65 years. * Both sexes. * American Society of Anesthesiologists (ASA) Physical status I and Ⅱ. * Schedule for elective umbilical hernia surgery under general anesthesia. Exclusion Criteria: * ASA Ⅲ or Ⅳ. * Patients with metabolic abnormalities, e.g., diabetes mellitus. * Patients receiving corticosteroids. * History of allergies to local anesthetics. * Bleeding or coagulation disorders. * Anatomical abnormalities. * Psychiatric and neurological disorders. * Complicated hernial defect (obstructed). * Patient refusal.

Contact & Investigator

Central Contact

Mayada H Sokeer, Master

✉ mayada.hady@med.tanta.edu.eg

📞 00201095315597

Frequently Asked Questions

Who can join the NCT07324863 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, up to 65 Years, studying Ultrasound. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07324863 currently recruiting?

Yes, NCT07324863 is actively recruiting participants. Contact the research team at mayada.hady@med.tanta.edu.eg for enrollment information.

Where is the NCT07324863 trial being conducted?

This trial is being conducted at Tanta, Egypt.

Who is sponsoring the NCT07324863 clinical trial?

NCT07324863 is sponsored by Tanta University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology